Broadcom delivered strong earnings guidance with its latest results, as CEO Hock Tan revealed a US$10 billion ASIC mass-production order from a major new customer outside the core hyperscale cloud ...

TL;DR: Broadcom secured a $10 billion custom ASIC contract from a major non-CSP client, with Apple, xAI, and ByteDance also in line. OpenAI's custom AI chip, produced with Broadcom and TSMC, aims to ...

Macquarie is weighing up whether to pay compensation to thousands of customers who lost money in the collapsed Shield Master Fund investment scheme, with the asset manager and banking giant locked in ...

Asics GT-1000 13 Grade School (Kids): was $75 now $49 at ASICS America With how active kids are on a daily basis, either at school, home, or in-between activities, investing in a high-quality pair of ...

ASIC has released the results of the latest adviser exam, with August’s pass mark improving on the sitting from a year ago. In the August exam, some 221 candidates sat the exam and 68 per cent of them ...

ASIC is celebrating an “important win” against Harvey Norman and lender Latitude over a misleading national advertising campaign that ran in newspapers, on radio and on television. Between 2020 and ...

The Australian understands Macquarie and the Australian Securities and Investments Commission have been in discussions for some weeks over a potential remediation program for the thousands of ...

This collaboration is a perfect example of Fieg’s ability to evolve a classic model while staying true to its original spirit. The Kith x ASICS Gel-Lyte III “Blue/White” is a perfect blend of a clean, ...

Incredibly bouncy ride Versatile across different speeds More breathable, race-orientated upper than the Superblast 2 FF Turbo Squared foam is soft underfoot When I tell people I test running shoes ...

We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Marvell Technology, Inc. (NASDAQ:MRVL) is one of the stocks Jim Cramer recently discussed. Marvell Technology, Inc.

Gift 5 articles to anyone you choose each month when you subscribe. Mayne Pharma and its advisers at investment bank Jefferies are under scrutiny from the corporate regulator, which has begun making ...